Ahmed Bahi on Lina Merghani’s Critique of Early Withdrawal of Aspirin after PCI
Ahmed Bahi, Critical Care Pharmacist Specialist in Trauma Services at Hamad Medical Corporation, shared on LinkedIn:
”Exciting News in Cardiovascular Research!
I’m thrilled to share that I recently had the opportunity to supervise my pharmD student Lina Merghani in critique of a groundbreaking study published in NEJM focused on the ”early withdrawal of aspirin after percutaneous coronary intervention (PCI) in acute acute coronary syndrome (ACS)”..
In my critique, Dr Lina highlighted benefit vs risk of stopping aspiring after acute ACS.
I want to commend our PharmD student for their hard work and dedication to advancing care for trauma patients.
Your contributions are paving the way for improved patient outcomes.
Let’s continue to push the boundaries of knowledge and improve the lives of our patients.”
Read the full article in NEJM.
Article: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
Authors: NEO-MINDSET Trial Investigators
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting